DC Field | Value | Language |
dc.contributor.author | Askari, I. V. | - |
dc.contributor.author | Osipova, O. A. | - |
dc.date.accessioned | 2022-04-22T16:31:39Z | - |
dc.date.available | 2022-04-22T16:31:39Z | - |
dc.date.issued | 2019 | - |
dc.identifier.citation | Askari, I.V. Influence of beta-blockers on mechanical dyssynchrony and cardiac remodeling in patients with ischemic chronic heart failure in the setting of revascularization / I.V. Askari, O.A. Osipova // Research Results in Pharmacology. - 2019. - Vol. 5, № 1.- P. 1-13. - Doi: 10.3897/rrpharmacology.5.34073. - Refer.: p. 11-13. | ru |
dc.identifier.uri | http://dspace.bsu.edu.ru/handle/123456789/46302 | - |
dc.description.abstract | Diastolic dysfunction (DD) and cardiac dyssynchrony (DS) are involved in the progression of chronic heart failure (CHF). A comparative analysis was conducted of the effect of a 6-month course of nebivolol and bisoprolol on DD, DS and metalloproteinase-9 (MMP-9) level in patients with ischemic chronic heart failure with preserved ejection fraction (HFpEF) and with midrange ejection fraction (HFmrEF), as well as in patients with comorbid type 2 diabetes mellitus (T2DM) in the setting of coronary artery bypass grafting (CABG) after 6 months of therapy | ru |
dc.language.iso | en | ru |
dc.subject | medicine | ru |
dc.subject | pharmacology | ru |
dc.subject | chronic heart failure | ru |
dc.subject | coronary heart disease | ru |
dc.subject | dyssynchrony | ru |
dc.subject | diastolic function | ru |
dc.subject | coronary artery bypass grafting | ru |
dc.subject | metalloproteinase-9 | ru |
dc.subject | nebivolol | ru |
dc.subject | bisoprolol | ru |
dc.title | Influence of beta-blockers on mechanical dyssynchrony and cardiac remodeling in patients with ischemic chronic heart failure in the setting of revascularization | ru |
dc.type | Article | ru |
Appears in Collections: | Vol. 5, № 1
|